Author: tianli

SDS of cas: 6285-57-0In 2020, Tiwari, Monika R.;Patel, Navin B. published 《Synthesis, characterization and biological studies of thiazolidinone analogues》. 《Journal of Applicable Chemistry (Lumami, India)》published the findings. The article contains the following contents:

A new series of 2-(4-substituted phenyl)-3-(6-substituted benzo [d]thiazol-2-yl)thiazolidin-4-one derivatives I [R = pyridin-4-yl, 4-hydroxy-3-methylphenyl, 4-chlorophenyl, etc.; R¹ = MeO, O₂N] were prepared by hybridization of two different biol. active moieties benzothiazole and thiazolidinone. The structures of the newly synthesized compounds I were established on the basis of spectral data (IR, ¹H and ¹³C NMR) and elemental anal. All the synthesized compounds I were tested for antibacterial activity against Gram-pos. bacteria (S. aureus, S. pyogenes) and Gram-neg. bacteria (C. albicans, A. niger, A. clavatus), antifungal activity against three fungi (C. albicans, A. niger, A. clavatus) using the MIC (Minimal Inhibitory Concentration) method, anti-tubercular activity H37Rv using L. J. Slope Method. Results of biol. screening revealed that compounds I [R1 = O₂N; R = 4-chlorophenyl, 4-methylthiophenyl, 4-methylphenyl, 3-methyl-4-hydroxyphenyl, R1 = MeO; R = 4-fluorophenyl, 4-trifluoromethylphenyl] showed good antibacterial activity where as I [R1 = O₂N; 4-chlorophenyl, R1 = MeO, R = furan-2-yl] and showed good antifungal activity and compound I [R1 = O₂N; R = 4-bromophenyl] showed good antitubercular activity. To complete the study, the researchers used 6-Nitrobenzo[d]thiazol-2-amine (cas: 6285-57-0) .

6-Nitrobenzo[d]thiazol-2-amine(cas:6285-57-0 SDS of cas: 6285-57-0) is an antimicrobial agent that inhibits bacterial growth by cleaving the peptide bonds of proteins. It has been shown to be active against a number of microorganisms, including Gram-positive and Gram-negative bacteria, as well as fungi.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Reference of 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetateIn 2022, Ferreira de Lima, Nayana;de Andrade Picanco, Guaraciara;Costa, Tatiane Luiza;Vinaud, Marina Clare published 《In vitro metabolic stress induced by nitazoxanide and flubendazole combination in Taenia crassiceps cysticerci》. 《Experimental Parasitology》published the findings. The article contains the following contents:

Taenia crassiceps is often used as exptl. model for T. solium cysticercosis studies. Currently cysticercosis antiparasitic treatment is based on albendazole and praziquantel which may present side effects and parasitic resistance. The search for other antiparasitic drugs is necessary. Nitazoxanide (NTZ) and flubendazole (FLB) are broad spectrum antiparasitic drugs that present anti-cysticercosis effect. Metabolic analyses help to determine the impact of these drugs on parasites. The aim of this study was to determine the impact on the production and excretion of organic metabolites in T. crassiceps cysticerci after in vitro exposure to NTZ and FLB, isolated or in combination. T. crassiceps cysticerci were culture in RPMI medium and exposed to 10 μg/mL of NTZ, 10 μg/mL of FLB or 10 μg/mL of NTZ +10 μg/mL of FLB. 24 h after exposure, the parasites were chromatog. analyzed to determine the impact of these drugs on glycolysis, homolactic fermentation, tricarboxylic acid cycle, fatty acids oxidation and proteins catabolism. It was possible to determine that the drugs combination induced greater metabolic impact on cysticerci in comparison to the isolated drugs exposure. The drugs combination induced gluconeogenesis, metabolic acidosis, increase in tricarboxylic acid cycle and in proteins catabolism. While the NTZ isolated exposure induced metabolic acidosis and protein catabolism and the FLB isolate exposure induced gluconeogenesis and protein catabolism. These results show that the combination of drugs with different modes of action increase the antiparasitic effect and may be indicated as alternative cysticercosis treatments. To complete the study, the researchers used 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate (cas: 55981-09-4) .

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate(cas: 55981-09-4), a thiazolide compound, is a antiparasitic drug with structure similar to niclosamide.Reference of 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Synthetic Route of C7H5N3O2SIn 2021, Giovannucci, Tatiana A.;Salomons, Florian A.;Haraldsson, Martin;Elfman, Lotta H. M.;Wickstroem, Malin;Young, Patrick;Lundbaeck, Thomas;Eirich, Jurgen;Altun, Mikael;Jafari, Rozbeh;Gustavsson, Anna-Lena;Johnsen, John Inge;Dantuma, Nico P. published 《Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound》. 《Cell Death & Disease》published the findings. The article contains the following contents:

Malignant cells display an increased sensitivity towards drugs that reduce the function of the ubiquitin-proteasome system (UPS), which is the primary proteolytic system for destruction of aberrant proteins. Here, we report on the discovery of the bioactivatable compound CBK77, which causes an irreversible collapse of the UPS, accompanied by a general accumulation of ubiquitylated proteins and caspase-dependent cell death. CBK77 caused accumulation of ubiquitin-dependent, but not ubiquitin-independent, reporter substrates of the UPS, suggesting a selective effect on ubiquitin-dependent proteolysis. In a genome-wide CRISPR interference screen, we identified the redox enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1) as a critical mediator of CBK77 activity, and further demonstrated its role as the compound bioactivator. Through affinity-based proteomics, we found that CBK77 covalently interacts with ubiquitin. In vitro experiments showed that CBK77-treated ubiquitin conjugates were less susceptible to disassembly by deubiquitylating enzymes. In vivo efficacy of CBK77 was validated by reduced growth of NQO1-proficient human adenocarcinoma cells in nude mice treated with CBK77. This first-in-class NQO1-activatable UPS inhibitor suggests that it may be possible to exploit the intracellular environment in malignant cells for leveraging the impact of compounds that impair the UPS.6-Nitrobenzo[d]thiazol-2-amine (cas: 6285-57-0) were involved in the experimental procedure.

6-Nitrobenzo[d]thiazol-2-amine(cas:6285-57-0 Synthetic Route of C7H5N3O2S) inhibits the activity of amines, which are small molecules found in many pharmaceuticals. The chemical structure of this drug contains one or more methylene groups that can be activated by diazonium salt to form an intermediate molecule with a reactive amine group.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Application In Synthesis of 6-Nitrobenzo[d]thiazol-2-amineIn 2021, Pandey, Himanshu;Shrivastava, S. P. published 《One pot synthesis, characterization of benzothiazole/benzimidazole tethered imidazole derivatives using clay as catalyst》. 《Oriental Journal of Chemistry》published the findings. The article contains the following contents:

A green approach for benzothiazole/benzimidazole tethered imidazole derivative synthesis utilizing brick derived clay as a catalyst were reported. Brick clay catalyst used in this synthesis were shown excellent catalytic activity by increasing efficiency, reducing the reaction time and most importantly it was reusable for further reaction runs. These derivatives were synthesized by multi component condensation reaction that involved benzil, aldehyde, 2-aminobenzimidazole/2-amino-6-nitrobenzothiazole and ammonium acetate. The clay catalyst was characterized by FT-IR while the synthesized derivatives were characterized by FT-IR, ¹H NMR and ¹³C NMR. Brick clay was a cheap, non-hazardous catalyst and were reused up to many reaction runs with good to excellent yields. And 6-Nitrobenzo[d]thiazol-2-amine (cas: 6285-57-0) was used in the research process.

6-Nitrobenzo[d]thiazol-2-amine(cas:6285-57-0 Application In Synthesis of 6-Nitrobenzo[d]thiazol-2-amine) is an antimicrobial agent that inhibits bacterial growth by cleaving the peptide bonds of proteins. It has been shown to be active against a number of microorganisms, including Gram-positive and Gram-negative bacteria, as well as fungi.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Category: thiazole《Shortened alkaline dyeing of polyester fabric using heterocyclic benzothiazole dyes》 was published in 2021. The authors were Jiang, Tingting;Hou, Aiqin;Zheng, Changwu;Xie, Kongliang;Gao, Aiqin, and the article was included in《Yinran》. The author mentioned the following in the article:

Alk. dyeing of polyester fabric can shorten the traditional dyeing process, save energy and water. It is an important direction of energy conservation and emission reduction But alk. dyeing has a higher requirement on the structural stability of dyes. With 2-amino-6-nitrobenzothiazole as diazo component and N-substituted aniline as coupling component, five disperse dyes containing different N-substituents were designed and synthesized. The dyeing properties of polyester fabric with disperse dyes under different NaOH concentrations (1-5 g/L) were tested. The relationship between dye structure and dyeing stability under basic dyeing conditions was discussed. The dyeing properties of dyes with different structures under acid and alkali conditions were compared. The results show that the hybrid dyes with Et and benzyl structure has good alkali resistance stability, acid and alkali dyeing condition does not have obvious influence on the dyeing rate of the two dyes, and the dyeing fastness is good. The experimental procedure involved many compounds, such as 6-Nitrobenzo[d]thiazol-2-amine (cas: 6285-57-0) .

6-Nitrobenzo[d]thiazol-2-amine(cas:6285-57-0Category: thiazole) has been shown to lower blood pressure in mice by inhibiting angiotensin converting enzyme and potassium channels. This drug also has a protective effect on the heart and brain from ischemia reperfusion injury.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Safety of 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetateIn 2022, Ebrahimi, Mahsa;Akhavan, Omid published 《Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2》. 《Catalysts》published the findings. The article contains the following contents:

A review. The COVID-19 pandemic has been transformed into one of the main worldwide challenges, in recent years. For controlling symptoms that are caused by this disease (e.g., chills or fever, shortness of breath and/or difficulty in breathing, cough, sore throat, fatigue, headache, muscle aches, the new loss of tastes and/or smells, congestion or runny nose, nausea, vomiting and/or diarrhea), lots of medicines including analgesics, mucolytics, and anti-biotic/viral/inflammatory drugs have been frequently prescribed. As these medicines finally contaminate terrestrial and aquatic habitats by entering surface waterways through pharmaceutical production and excreting trace amounts of waste after human usage, they have neg. impacts on wildlife′s health and ecosystem. Residual drugs in water have the potential to harm aquatic creatures and disrupt their food chain as well as the breeding cycle. Therefore, proper degradation of these broadly used medicines is highly crucial. In this work, the use of nanomaterials applicable in photocatalytic degradations of analgesics (e.g., acetaminophen, aspirin, ibuprofen, and naproxen), mucolytics (e.g., ambroxol), antibiotics (e.g., azithromycin and quinolones including hydroxychloroquine and chloroquine phosphate), anti-inflammatory glucocorticoids (e.g., dexamethasone and cortisone acetate), antihistamines (e.g., diphenhydramine), H2 blockers (e.g., famotidine), anthelmintics (e.g., praziquantel), and finally antivirals (e.g., ivermectin, acyclovir, lopinavir/ritonavir, favipiravir, nitazoxanide, and remdesivir) which widely used in controlling/treating the coronavirus have been reviewed and discussed. To complete the study, the researchers used 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate (cas: 55981-09-4) .

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate(cas: 55981-09-4) has been approved as an orphan drug for the treatment of diarrhea in children (age, 1–11 years) and is associated with giardiasis, but it also is approved for diarrhea caused by crytosporidiosis in patients with AIDS.Safety of 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Apaydin, Cagla Begum;Cinar, Gozde;Cihan-Ustundag, Gokce published 《Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19》 in 2021. The article was appeared in 《Current Drug Targets》. They have made some progress in their research.Related Products of 55981-09-4 The article mentions the following:

A review. The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Dec. 2019 and has rapidly spread globally. As the confirmed number of cases has reached 83 million worldwide, the potential severity and the deadly complications of the disease requires urgent development of effective drugs for prevention and treatment. No proven effective treatment for this virus currently exists. Most of the antiviral discovery efforts are focused on the repurposing of approved or clin. stage drugs. This review highlights the small-mol. repurposed antiviral agents that are currently under investigation in clin. trials for COVID-19. These include viral polymerase and protease inhibitors remdesivir, galidesivir, favipiravir, ribavirin, sofosbuvir, tenofovir/emtricitabine, baloxavir marboxil, EIDD-2801, lopinavir/ritonavir; virus-/host-directed viral entry and fusion inhibitors arbidol chloroquine/hydroxychloroquine, chlorpromazine, camostat mesylate, nafamostat mesylate, bromhexine and agents with diverse/unclear mechanism of actions as oseltamivir, triazavirin, ivermectin, nitazoxanide, niclosamide and BLD-2660. The published preclin. and clin. data to date on these drugs as well as the mechanisms of action are reviewed.2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate (cas: 55981-09-4) were involved in the experimental procedure.

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate(cas: 55981-09-4) has been approved as an orphan drug for the treatment of diarrhea in children (age, 1–11 years) and is associated with giardiasis, but it also is approved for diarrhea caused by crytosporidiosis in patients with AIDS.Related Products of 55981-09-4

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Formula: C7H5N3O2S《Synthesis, Characterization and Biological Potency of Butyl-Pyridone Based Azo Dyes》 was published in 2020. The authors were Kumar, Vinod;Keshavayya, J.;Matada, Mallikarjuna N.;Srinivasa, Sudhanva M.;Rangappa, S., and the article was included in《ChemistrySelect》. The author mentioned the following in the article:

A series of heterocyclic disperse azo dyes having pyridone architecture was prepared by a simple, economical and highly efficient diazo-coupling method. In this method, Bu pyridone was used as a common coupling component by changing the five heterocyclic amine moieties. The structural investigations of the analogous compounds were accomplished by various spectroscopic techniques. Further, all the azo dyes were examined for their potency towards antibacterial, antituberculosis and anticancer activities. The results revealed that all the dye mols. exhibited excellent tuberculosis activity and also very promising anticancer activity. In the case of the antibacterial assay, only a few azo dyes displayed good inhibition effect towards the tested bacterial strains. And 6-Nitrobenzo[d]thiazol-2-amine (cas: 6285-57-0) was used in the research process.

6-Nitrobenzo[d]thiazol-2-amine(cas:6285-57-0 Formula: C7H5N3O2S) inhibits the activity of amines, which are small molecules found in many pharmaceuticals. The chemical structure of this drug contains one or more methylene groups that can be activated by diazonium salt to form an intermediate molecule with a reactive amine group.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Pinheiro, Tiago Novaes;Leite, Milena Gomes Melo;da Silva, Cristiane Cantiga;Alexandre, Cleber Nunes;Cabral, Lioney Nobre;Carvalho, Hannah Marcelle Paulain;de Souza, Daniel Frota;Goncalves, Jessica Lourdes de Aguiar;de Souza, Thales Edecherly Nasserala;Melo, Nara Deise de Souza;Cintra, Luciano Tavares Angelo;Kanehira, Beatriz Terumi Barreto;de Albuquerque, Gustavo Cavalcanti published 《Comparative evaluation of vegetable matter involved lesions with oral parasitic infections in the oral cavity》. The research results were published in《Microscopy Research and Technique》 in 2022.Computed Properties of C12H9N3O5S The article conveys some information:

The current research aims to perform a comparative evaluation of vegetable matter involved lesions with oral parasitic infections found in oral mucosa, presenting histochem. methods to differentiate their microscopic similarities. Eight cases were selected out of a sample of 1.975 reports from a single Oral and Maxillofacial Pathol. Service of the authors institution from 2012 to 2019. Specimens were examined by hematoxylin and eosin staining (HE), periodic acid-Schiff (PAS) staining, Gomori-Grocott staining, Ziehl-Neelsen staining, Giemsa, and mucicarmine staining. Microscopic anal. included fluorescence, polarized light, and confocal microscopy. Microscopically, in HE coloration, hookworm eggs showed as eosinophilic. Inflammatory multinucleated giant cells and lymphocytes, were usually related to the nematode eggs, forming an intense inflammatory infiltrate. Biofluorescent properties of eggs and larvae revealed to be sensitive in the detection of parasitic structures contrasting with the inflamed connective tissue. Vegetable presence was confirmed by polarized light microscopy and it was found to be associated with microbial biofilms. Confocal microscopy has showed to be an excellent method for morphotype differentiation of parasitic eggs. Parasitic infection and vegetable matter displayed similarities in the inflammatory response, but the latter can rot and agglomerate biofilms. The microscopic diagnosis of such infections requires the interpretation of challenging morphol. features since the parasites are usually sectioned and mixed with an inflammatory reaction. These histochem. approaches proved to be excellent to distinguish both lesions. The experimental procedure involved many compounds, such as 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate (cas: 55981-09-4) .

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate(cas: 55981-09-4) has been approved as an orphan drug for the treatment of diarrhea in children (age, 1–11 years) and is associated with giardiasis, but it also is approved for diarrhea caused by crytosporidiosis in patients with AIDS.Computed Properties of C12H9N3O5S

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Formula: C12H9N3O5S《Phenotypic screening techniques for Cryptosporidium drug discovery》 was published in 2021. The authors were Love, Melissa S.;McNamara, Case W., and the article was included in《Expert Opinion on Drug Discovery》. The author mentioned the following in the article:

A review. Two landmark epidemiol. studies identified Cryptosporidium spp. as a significant cause of diarrheal disease in pediatric populations in resource-limited countries. Notably, nitazoxanide is the only approved drug for treatment of cryptosporidiosis but shows limited efficacy. As a result, many drug discovery efforts have commenced to find improved treatments. The unique biol. of Cryptosporidium presents challenges for traditional drug discovery methods, which has inspired new assay platforms to study parasite biol. and drug screening. The authors review historical advancements in phenotypic-based assays and techniques for Cryptosporidium drug discovery, as well as recent advances that will define future drug discovery. The reliance on phenotypic-based screens and repositioning of phenotypic hits from other pathogens has quickly created a robust pipeline of potential cryptosporidiosis therapeutics. The latest advances involve new in vitro culture methods for oocyst generation, continuous culturing capabilities, and more physiol. relevant assays for testing compounds Previous phenotypic screening techniques have laid the groundwork for recent cryptosporidiosis drug discovery efforts. The resulting improved methodologies characterize compound activity, identify, and validate drug targets, and prioritize new compounds for drug development. The most recent improvements in phenotypic assays are poised to help advance compounds into clin. development. To complete the study, the researchers used 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate (cas: 55981-09-4) .

2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate(cas: 55981-09-4), an anthelmintic agent, exhibits a broad spectrum of activities against a wide variety of helminths, protozoa, and enteric bacteria infecting animals and humans.Formula: C12H9N3O5S

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica